Mon.Sep 19, 2022

article thumbnail

Med-tech and health facilities: A cybersecurity house of mirrors

MedCity News

Much like a house of mirrors, responsibility for understanding and mitigating cyber risk in healthcare is difficult to distinguish and often depends on who you ask, especially when it comes to non-enterprise systems and devices.

article thumbnail

EMA CHMP recommends authorisation of AstraZeneca’s Evusheld for Covid-19

Pharmaceutical Technology

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation for AstraZeneca ’s Evusheld (formerly AZD7442) for Covid-19 in the European Union (EU). This therapy is intended to treat adult and adolescent Covid-19 patients aged 12 years and above, who do not need additional oxygen and are at greater disease progression risk.

Medicine 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why VR could be the new dawn of pain, anxiety management

MedCity News

Experts think virtual reality (VR) can help address the country’s rising levels of pain and anxiety. By flooding the brain with positive signals, VR experiences can act as a drug-free alternative to pain and mental health management — and hospitals across the nation are deploying the technology.

article thumbnail

Lupin Limited – Walk-In Interview for Quality Control On 20th September 2022

Pharma Pathway

Lupin Limited – Walk-In Interview for Quality Control On 20th September 2022. Job Description. Department: Quality Control. Designation: Officer/ Executive. Experience : 02- 07 years. Job Location: Visakhapatnam. Desired Candidate profile: Analysis of Raw Materials, Inprocess, Intermediate finished products & Stability analysis by HPLC, GC, PSD, pXRD, IR, UV, & KF instruments.

Pharma 87
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

‘It’s creating change’: How some startups are circumventing payers

MedCity News

Many startups are giving patients options to receive care that cuts out insurers. This includes online pharmacies, direct primary care platforms and lending companies. These startups are creating change among payers, some experts say.

Insurance 106
article thumbnail

Soft Robot Biodegrades Inside Body

Medgadget

Researchers at the City University of Hong Kong have developed a magnetic soft millirobot that can grab and release objects, and move around by rolling. The device can be controlled using magnetic fields, and consists of a biodegradable gelatin and iron oxide microparticles. The technology has significant potential as a minimally invasive drug delivery system, perhaps in the gastrointestinal tract, and may even lead to soft robots that can carry out surgical procedures within the body.

More Trending

article thumbnail

Sai Life Sciences Limited- Walk-In Interview for Production- Chemists On 25th Sept’ 2022

Pharma Pathway

Sai Life Sciences Limited- Walk-In Interview for Production- Chemists On 25th Sept’ 2022. Job Description. Sai Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions, through a broad suite of expert capabilities across the molecular lifecycle. Interested and eligible candidates can attend interview on scheduled Time & Venue.

article thumbnail

Genfit spreads its bets in a rare liver disease with buyout of Phase 2-ready biotech

MedCity News

Liver disease remains the focus of Genfit, despite a high-profile clinical trial failure in the fatty liver disease NASH. The company is building out its pipeline by acquiring Versantis, a clinical-stage biotech whose most advanced drug candidate brings a novel approach to treating a deadly chronic liver disease complication that has no FDA-approved therapies.

FDA 96
article thumbnail

Challenges in the Medical Sales Industry

MedReps

There’s no shortage of challenges for those new to pharma, medical sales and even veterans. Often we’re lucky if we even get to see our physicians, let alone overcome their objections regarding insurance coverage and competitive claims. Then, there are internal hurdles like compliance standards and ever-increasing goals. As a result, a job known for its high compensation and prestige can appear much more gritty and taxing.

article thumbnail

Inflation’s impact on healthcare switchboards and call centers [Sponsored]

MedCity News

Hospitals struggle to retain switchboard and call center staff, a situation exacerbated by inflation. Here’s how Parlance is leveraging its call automation tech to help address these needs and improve the caller experience.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

4 Reasons Why Customer 360* is Important to Close More Deals

Toolyt

According to the study conducted by Gartner in 2022, only 14% of organizations have achieved a customer 360* view. When everyone is pushing hard to get more data on customers, often it paves way for incorrect, bad, and risky data, ultimately leading to negative customer support. In the current market trends, understanding what customers want from you paves the way to long-term success.

CRM 52
article thumbnail

WELL by HLTH program builds on consumerization of healthcare trend [Sponsored]

MedCity News

Among the topics of discussion at the event within the HLTH conference are: making the future of food and nutrition accessible and sustainable, managing and monitoring sleep health, and destigmatizing sexual health and wellness. Register today!

article thumbnail

Genfit builds rare liver disease pipeline with Versantis buy

pharmaphorum

French pharma company Genfit has reached a deal to buy Versantis of Switzerland, adding three development-stage drug candidates to its portfolio of experimental liver disease therapies and continuing a strategy change first unveiled in 2020. That change was forced by disappointing clinical trial results with Genfit’s lead drug elafibranor in non-alcoholic steatohepatitis (NASH), and included a pledge to build a pipeline in rare liver diseases behind elafibranor – now redirected at primary

Leads 52
article thumbnail

Confronting burnout head on: 3 ways nursing home owners can protect the health and happiness of their nurses

MedCity News

More flexibility and control over shift scheduling, tools to reduce admin burnout, and same-day pay all go a long way in helping to relieve the looming burnout crisis.

96
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Benefits and Challenges of Telehealth to Consider in Healthcare

Medico Reach

The effective adoption of telehealth gained momentum after the pandemic phase. Today, healthcare companies and experts are capitalizing on this technology to refine their services. Almost 44% of physicians forecast telehealth use to attend to half of their appointments. Hence, telemedicine is here to stay and grow exponentially, be it in local retail clinics or large-scale healthcare organizations.

article thumbnail

Glen Tullman on launching Transcarent Pharmacy Care: Unlike others, we are a one-stop-shop

MedCity News

Transcarent is the latest to join a long list of companies hoping to transform the world of pharmacy benefits and prescription drugs. But its CEO declares Transcarent is marrying healthcare delivery with easy, affordable access to pharmaceuticals and creating a more unified experience for employees.

article thumbnail

Microlearning Monday

CLD, Inc.

As a training manager, you can make short Monday training assignments work for you. After new hire training, sales representatives often complain that it was all “too much too fast.” Representatives absorb as much as possible, but most would benefit from additional training that refreshes their memory of key topics and helps them apply their knowledge and skills.

article thumbnail

Ensuring reliable access to affordable sexual and reproductive care in uncertain times

MedCity News

To more effectively implement meaningful solutions that help ensure that access to affordable sexual and reproductive healthcare is treated as a right and not a privilege, we must identify and examine why these challenges persist.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

EC grants approval for BMS’ Opdualag to treat melanoma

Pharmaceutical Technology

The European Commission (EC) has granted approval for Bristol Myers Squibb ’s (BMS) fixed-dose combination, Opdualag (nivolumab and relatlimab), as first-line therapy to treat advanced (unresectable or metastatic) melanoma. The treatment is indicated for usage in adult and adolescent patients aged 12 years and above with tumour cell PD-L1 expression less than 1%.

article thumbnail

Abbott’s HeartMate 3 extends life by 5 years for advanced heart failure patients

MedCity News

It is the first LVAD trial to examine five-year outcomes and surpasses a previous Abbott study on HeartMate 3, which recorded a survival time of two years. The device was found to reduce morbidity and mortality, largely because of fewer deaths by stroke, clotting and bleeding.

article thumbnail

Selmar Lab Pvt. Ltd-Walk-In Interview for Quality Assurance Dept. On 20th & 21st Sept’ 2022

Pharma Pathway

Selmar Lab Pvt. Ltd-Walk-In Interview for Quality Assurance Dept. On 20th & 21st Sept’ 2022. Job Description. Selmar Lab Pvt. Ltd is located at Sy. No. 180/1 to 180/15 and 10/1, IDA, Kazipally, Jinnaram Mandal, Sangareddy District, Telangana. Selmar Lab Pvt. Ltd, We are Conducting Walk-In Interviews for Following.!!! Walk-In Interview for Quality Assurance Dept.

Safety 52
article thumbnail

Bluebird Bio gene therapy becomes first FDA-approved med for ultra-rare neuro disorder

MedCity News

Bluebird Bio gene therapy Skysona has won FDA approval, making it the first FDA-approved therapy for cerebral adrenoleukodystrophy, an ultra-rare and fatal neurological disorder. Skysona’s regulatory green light follows the August approval of Zynteglo, a Bluebird gene therapy for a rare blood disorder.

FDA 87
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

What Is A Medical Sales Job Hopper?

Medical Sales Authority

Job hopping is becoming more popular these days. This is not a good thing in sales. Moving around roles every few years has become common for millennials. This may work in the technology sector where engineers are able to jump in and immediately contribute in a role. This does not pan out in sales. There are so much administrative tasks just to get started in an outside sales job.

article thumbnail

4 Reasons Why Customer 360* is Important to Close More Deals

Toolyt

According to the study conducted by Gartner in 2022, only 14% of organizations have achieved a customer 360* view. When everyone is pushing hard to get more data on customers, often it paves way for incorrect, bad, and risky data, ultimately leading to negative customer support. In the current market trends, understanding what customers want from you paves the way to long-term success.

CRM 52
article thumbnail

Peer Review Week 2022: A Matter of Trust?

Copyright Clearance Center

The post Peer Review Week 2022: A Matter of Trust? appeared first on Copyright Clearance Center.

74
article thumbnail

Options for Immunoglobulin Administration Allow for Personalized Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

Pharmacy Times

Although there is no “best” way to determine which route of administration is best, health care providers are optimally positioned to educate patients and help them make the best decision.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

2022 “Global 50” Rankings for Publishers

Copyright Clearance Center

The post 2022 “Global 50” Rankings for Publishers appeared first on Copyright Clearance Center.

52
article thumbnail

Unique Offerings, Curriculum to Prepare for Cultural Differences

Pharmacy Times

The most important thing you must do is listen to the patient, understand their concerns, and by doing that, you will gain their trust to be able to treat them appropriately.

article thumbnail

Rare Ability: US-Based CDMO Has Available Fill/Finish Capacity, Development & Testing

PharmaTech

Discovery the industry's best kept secret.a fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing, and fill/finish cGMP manufacturing for sterile injectable and topical products – all under one roof. Whether your drug product is liquid or lyo, aseptically filled or requires terminal sterilization, the August Bio team brings to bear more than two decades of drug development and launch expertise.

article thumbnail

Older Adults With Herpes Zoster Have Unique Considerations

Pharmacy Times

Pharmacists can educate older adults on risk factors and prevention efforts around herpes zoster.

article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.